Cytek Investor Day Presentation Deck slide image

Cytek Investor Day Presentation Deck

Overview of Our Key Business Components Revenue Components Instruments Reagents / Applications Software Services Background Our instrument revenue primarily consists of sales of our Aurora and Northern Lights and Cell Sorter systems, instrument accessories, such as loaders ā— ā— We offer multiple versions of our Aurora and Northern Lights and Cell Sorter systems with different price points based on the number of lasers integrated in the systems We also derive revenue from sales of our conventional flow cytometry system, which is available for sale in China We recognize product revenue when control of the instrument is transferred to the customer We currently offer and are developing an additional range of kits and single vial reagents for both the Clinical and RUO (human & mouse) markets. As a full flow cytometry solutions provider, we are aggressively expanding our reagent offering of kits, single vial reagents, and paid panel design, support, and validation services to meet our customers' needs and to drive the continued and expanded adoption of our superior technology into both the Clinical and RUO markets. Our software is integrated into our instruments free of charge Our service revenue primarily consists of post-warranty service contracts, installations and repairs which are recognized over time Post-warranty service contracts are recognized ratably over the term of the contract and installations and repair services are recognized as they are delivered to the customer CYTEK TRANSCEND THE CONVENTIONAL 124
View entire presentation